Ke Cheng

Columbia Univ New York Morningside

Professor of biomedical engineering, 13 Mar 2024, reporter.nih.gov

National Heart, Lung, and Blood Institute

R01, Drug Delivery and Biomimetic Approaches for Optimal Stem Cell Therapy, R01HL154154, 2021–2026, 13 Mar 2024, reporter.nih.gov